ライフサイエンスコーパス: decoy

1 been shown to function as an APRIL-specific decoy.

2 active when the chosen option dominated the decoy.

3 te that neutralizes infection by acting as a decoy.

4 ilar results can be achieved using only 2000 decoys.

5 directly control the diversity of generated decoys.

6 of competitor DNA duplexes, including Egr-1 decoys.

7 igands form more-resilient interactions than decoys.

8 the native state with respect to structural decoys.

9 nked 1st, 1st and 10th among 54 000 possible decoys.

10 duced by standard Rosetta while using 20,000 decoys.

11 protein models and identify good models from decoys.

12 decoy sets consisting of mostly low-quality decoys.

13 sion of Rosetta is able to deliver with 2000 decoys a performance equivalent to that produced by stan

14 Analyses of tough decoy abundance in hepatocyte genomic DNA and input plas

15 nRNP L sequesters miR-574-3p, overcoming its decoy activity and seed sequence-dependent gene silencin

16 DNA methylation of decoys alone did not affect target search kinetics.

17 Decoys also yielded anecdotal information, furthering ou

18 thasone, inhibition of miR-433 using a tough decoy altered the period and amplitude of Per2 gene expr

19 targets available in the Directory of Useful Decoys and the performance was evaluated using the area

20 bsolute scores, identify the best model from decoys, and distinguish between good and bad models.

21 of dabigatran, the investigational factor Xa decoy andexanet alfa, and the synthetic small molecule c

22 eral HIV-protease inhibitors can function as decoy antigens to specifically inhibit the binding of an

23 ve flexibility, producing new small-molecule decoy antigens, which neutralize anti-dsDNA antibodies i

24 This decoy approach has since been translated into crop speci

25 T cells using a peptide approach; a receptor decoy approach using an analogue of Fcgamma receptor IIB

26 This "decoy" approach may be applicable to other NLR proteins

27 Over the past two decades, target-decoy approaches (TDAs) and decoy-free approaches (DFAs)

28 CD4-based decoy approaches against HIV-1 are attractive options fo

29 These results suggest that when decoys are methylated, MBD proteins can block them and t

30 st challenging regions, such as coils, fewer decoys are needed to explore satisfactorily conformation

31 n-native protein structure conformations (or decoys) are often used for designing protein folding sim

32 nding of TFs and highlights the dual role of decoys as attenuators or amplifiers of gene expression n

33 ow-energy conformations (also referred to as decoys) as a way of increasing the likelihood of having

34 TF, can employ an exhaustive sampling during decoy assembly.

35 We present empirical Bayes and target-decoy based methods to estimate the false discovery rate

36 In normoxia, miR-574-3p, acting as a decoy, binds cytoplasmic hnRNP L and prevents its bindin

37 jects with distinct patterns of responses to decoys, both of which depended on individuals' risk aver

38 Prior studies have assumed that decoy-bound TFs are protected from degradation, and in t

39 lockade, we engineered a bispecific receptor decoy by attaching the TGF-beta-neutralizing TGFBR2 extr

40 orithm, 3DRobot, to create protein structure decoys by free fragment assembly with enhanced hydrogen-

41 ; however, with the addition of an inferior "decoy" C, females reversed their preferences and chose A

42 effect": introducing an irrelevant option (a decoy) can influence choices among other (relevant) opti

43 Combining decoy cell and BK viremia in a diagnostic matrix improve

44 [PCR]) and BK viruria (quantitative PCR and decoy cell counts).

45 t to conventional quantitative PCR assays or decoy cell counts, quantitative urinary PV-Haufen testin

46 No correlations were seen with urinary decoy cell counts.

47 erformance of quantitative viremia surpassed decoy cells (area under the curve of 0.95 and 0.79, resp

48 d the diagnostic test performance of urinary decoy cells and urinary SV40T immunochemistry of exfolia

49 Although quantified decoy cells are acceptable surrogate markers of BK viral

50 Quantification of decoy cells improved the PPV to 32.1% (10 >/= cells thre

51 Decoy cells occurred in 95 of 704 (13.5%) samples, with

52 protein abundance was unaffected in miR-433 decoy cells.

53 phropathy, any urine cytology demonstrating "decoy" cells, and/or significant polyomavirus BK viremia

54 ssion of an anti-inflammatory cytokine and a decoy chemokine receptor can modulate inflammatory proce

55 Here we test whether co-expression of the decoy chemokine receptor M3, that can scavenge inflammat

56 sify models as correct/incorrect; discarding decoys classified as incorrect led to an enrichment in t

57 In bottom-up discovery proteomics, target-decoy competition (TDC) is the most popular method for f

58 OID) that aims to generate highly compelling decoy complexes that are individually matched to availab

59 The best monovalent decoy, CTC-445.2, bound with low nanomolar affinity and

60 A bivalent decoy, CTC-445.2d, showed ~10-fold improvement in bindin

61 he learning task further improves the target-decoy database analysis for identifying peptides, which

62 e false discovery rate (FDR) from the target-decoy database search is typically deployed to filter id

63 The target-decoy database strategy is largely used for error estima

64 ncreasing the likelihood of having a diverse decoy dataset that covers a sufficient number of local m

65 er >98% of native-like models of CcdB from a decoy dataset.

66 luorescent response and activating NF-kappaB decoy DNA oligonucleotides.

67 Expression of the IQGAP1-IQ motif decoy domain in epidermal tissue in vivo inhibits oncoge

68 a-RGA5 interaction and the role of the RATX1 decoy domain of RGA5.

69 ent defense, and RPS4/RRS1 has integrated a "decoy" domain that enables detection of effectors that t

70 red plant immune receptors have incorporated decoy domains that structurally mimic pathogen virulence

71 advantage, of the combination of integrated decoy domains with additional independent effector-NLR i

72 ore on 174 native interactions for which 100 decoys each were constructed using ZDOCK.

73 atum when subjects successfully overrode the decoy effect and made unbiased choices.

74 results suggest that the neural basis of the decoy effect could be the context-dependent activation o

75 o investigate the neural underpinning of the decoy effect of both sexes.

76 exhibit a violation of rationality known as "decoy effect": introducing an irrelevant option (a decoy

77 the first group exhibited strong, consistent decoy effects and became more risk averse due to decoy p

78 in the second group did not show consistent decoy effects and became more risk seeking.

79 This model reveals that the three decoy effects are not distinct phenomena but are all spe

80 We found that observed distinct patterns of decoy effects can be explained by a combination of adjus

81 coloration mechanism, the nano-bioreplicated decoys evoked the complete attraction and landing sequen

82 One strategy involves encoding a decoy Fcgamma receptor (FcgammaR), which blocks Fc-media

83 assessed the efficacy of these "fluorescent decoy" (FD) sensors by characterizing active iron transp

84 a metabolite-signal match score and a target-decoy FDR estimate for spatial metabolomics.

85 , in part, to the deployment/secretion of a "decoy flare," for example, anomalous cancer-associated a

86 MutY possesses an exo-site that serves as a decoy for C, and secondly, repulsive forces with a key a

87 ods for automated generation of high-quality decoys for any target proteins.

88 tating the release of exosomes that serve as decoys for bacterially produced toxins.

89 tion transgenic mice overexpressing microRNA decoys for either miR-23a or miR-27a, but not miR24-2, s

90 al penton-dodecahedral particles that act as decoys for HD5, thus preventing the inactivation of viru

91 t retrotransposon-derived transcripts act as decoys for miR171, triggering its degradation and thus r

92 protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracell

93 mmatory signaling receptor, sRAGE acts as a "decoy" for RAGE ligands and prevents their interaction w

94 decades, target-decoy approaches (TDAs) and decoy-free approaches (DFAs) have been widely used to es

95 We introduce a new decoy-free framework for FDR estimation that generalizes

96 ResQ was further tested on structure decoys from CASP9-11 experiments, where the error of loc

97 fying one or more biologically-active/native decoys from millions of non-native decoys is one of the

98 igens that induce autoantibodies and exert a decoy function against complement-mediated cytotoxicity.

99 TMEM219 also contributed to the decoy function of IL-13Ralpha2.

100 of this cytokine, while Ralpha2 possesses a decoy function which can block IL-13 signaling.

101 ng NKR-P1A/C receptors to counterbalance m12 decoy function.

102 protected from degradation, and in this case decoys function to buffer noise.

103 ased sTACI is an immunoregulator that shares decoy functions with atacicept.

104 The decoys generated by 3DRobot are shown to have significan

105 tive structure than several state-of-the-art decoy generation algorithms.

106 a promising research direction in improving decoy generation for template-free protein structure pre

107 s, we propose that conformation sampling for decoy generation is more naturally framed as a multi-obj

108 ructure space probed through a template-free decoy generation.

109 prevalence, probably due to the existence of decoy glycan receptors in human gastrointestinal tract l

110 Substituents placing polar decoy groups into the pocket to capture putatively prese

111 ble to identify eight cases where no correct decoy had been generated.

112 vely generate a model to classify PSMs using decoy hits with increased sensitivity.

113 d that, when using the recommended number of decoys, i.e. 20,000, our strategy produces better result

114 aria of transgenic mice expressing a miR-433 decoy in osteoblastic cells (Col3.6 promoter), the ampli

115 Thus, Rcr3 acts as a guarded decoy in this interaction, trapping the fungus into a re

116 tive structure scored better than any of the decoys in 146 cases and was able to rank within the 95th

117 d to an enrichment in the proportion of good decoys in our final ensemble by a factor of seven.

118 an increase in the proportion of near-native decoys in the ensemble, leading to more accurate predict

119 and negative samples (native and non-native decoys) in a decoy set makes the problem even more compl

120 y active immunoreceptors, ligands, and viral decoys, including challenging cell surface proteins that

121 bition of DLL1/4 with ligand-specific Notch1 decoys increased sprouting of sinusoidal endothelial cel

122 ry simple model that can fully reproduce the decoy influence map and capture its variability in indiv

123 Our analysis reveals that the decoy influence map is highly structured even beyond the

124 ttribute space and constructed a full map of decoy influence on choices between two otherwise preferr

125 ve/native decoys from millions of non-native decoys is one of the major challenges in computational s

126 MV genome encodes for MHC class I-homologous decoy ligands for inhibitory NK cell receptors to evade

127 lasmid pools encoding more than 30,000 tough decoy miRNA inhibitors (hairpin nucleic acids designed t

128 d ability to recognize native structure from decoy models compared to other potentials.

129 n this contribution, we demonstrate that the decoy molecule approach enables conversion of a broad ra

130 nd therefore, TAR may be a dominant negative decoy molecule in cells.

131 another dimension for antiviral activity of decoy molecules.

132 osteocalcin, were also increased in miR-433 decoy mouse calvaria.

133 Further, multi-layer DNA sponges for decoying multiple regulatory proteins provide an additiv

134 using various techniques including receptor decoys, multiple co-operative binding sites, and sequent

135 lectively, our findings identify a molecular decoy naturally generated during apoptosis that inhibits

136 A soluble decoy (NgR1-Fc, AXER-204) blocks these ligands and provi

137 For low-affinity decoys, noise in the level of unbound TF always monotoni

138 In contrast, for high-affinity decoys, noise levels first increase with increasing deco

139 noise levels first increase with increasing decoy numbers, before decreasing back to the Poisson lim

140 creases to the Poisson limit with increasing decoy numbers.

141 etric inhibitors often function as molecular decoys of protein-binding partners or nucleic acid targe

142 With field experiments using predator decoys of the black grouper (Mycteroperca bonaci), we in

143 eport the development of an engineered STAT3 decoy oligodeoxynucleotide (dODN) that is stable in seru

144 Moreover, pretreatment of the cells with a decoy oligonucleotide carrying wild-type p53-response el

145 ucleotide to restore SMN and a complementary decoy oligonucleotide to neutralize its effects in the C

146 ned the kinetic impact of DNA methylation of decoys on the search process of the Egr-1 zinc-finger pr

147 novel mechanism by which ROR may serve as a decoy oncoRNA that blocks binding surfaces, preventing t

148 t with the hypothesis that the presence of a decoy option influences the valuation of other options,

149 inds to IL-13Ralpha2, considered as either a decoy or a key mediator of fibrosis.

150 d by Pii, suggesting a role for OsExo70 as a decoy or helper in Pii/AVR-Pii interactions.

151 A decoy peptide design based on this FLV motif could block

152 A decoy peptide disrupting the IL-17RA-NOTCH1 interaction

153 ts could be rescued by the treatment of this decoy peptide in both M17 cells overexpressing D620N or

154 we investigated the degree to which TLR TIR decoy peptide modified to include a TAT sequence (Trans-

155 Decoy peptide spanning HDAC1 K74 and RG 7112, an MDM2 in

156 define the binding site, we used a series of decoy peptides derived from the primary amino acid seque

157 The degree of change in risk aversion due to decoy presentation was positively correlated with the or

158 y effects and became more risk averse due to decoy presentation.

159 ientific commentary refers to 'Nogo receptor decoy promotes recovery and corticospinal growth in non-

160 and a single intranasal prophylactic dose of decoy protected Syrian hamsters from a subsequent lethal

161 es of various antibodies and ACE2-Fc soluble decoy protein in both assays revealed a high degree of c

162 t) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibit

163 regulation mechanism from nature, which uses decoy protein-binding DNA sites, named DNA sponge, to mo

164 Hence, decoy proteins encoding only a CARD or PYD, COPs and POP

165 lecule additive during the TMT labeling as a decoy reagent to deplete the excess amount of TMT reagen

166 We have used a soluble ActRIIB decoy receptor (ACVR2B/Fc) to test the effects of myosta

167 an ultra-high affinity soluble AXL Fc fusion decoy receptor (sAXL) reduced the growth of a pazopanib-

168 l, or as a soluble ectodomain that acts as a decoy receptor (sRAGE).

169 ved ectodomains of osteoprotegerin (OPG) and decoy receptor 3, other two secreted forms of TNFRSF, we

170 operties required the engagement of the IL-1 decoy receptor 8 (IL-1R8) and the activation of AMP-acti

171 ntagonist that outperforms the natural IL-33 decoy receptor and shows anti-inflammatory activities in

172 h neutralizing antibodies or the soluble IFN decoy receptor B18R nor by short hairpin RNA (shRNA) kno

173 sMerTK acts as a decoy receptor blocking the effect of both MerTK ligands

174 e illustrate how GIF serves as a competitive decoy receptor by leveraging binding hotspots underlying

175 iants that bind to the neutrophil-restricted decoy receptor CEACAM3.

176 By this route, we defined the decoy receptor DcR1 as a temozolomide response gene indu

177 xpression patterns, confirming its role as a decoy receptor for IL-13 signaling.

178 In contrast, soluble ST2 appears to act as a decoy receptor for IL-33, blocking myocardial and vascul

179 OPG is a decoy receptor for RANKL, thereby increasing BMD.

180 Osteoprotegerin (OPG), a secreted decoy receptor for receptor activator of nuclear factor

181 ernative to the widely used BAFF receptor-Fc decoy receptor for the specific depletion of BAFF in mic

182 pression of CyHV-3 ORF12, encoding a soluble decoy receptor for TNF-alpha, delayed the manifestation

183 ring ischaemia, soluble CD163 functions as a decoy receptor for TWEAK, a secreted pro-inflammatory cy

184 loyed by poxviruses, encoding four viral TNF decoy receptor homologues (vTNFRs) named cytokine respon

185 (IL-1) receptor 1 and high expression of the decoy receptor IL-1 receptor 2 and IL-1 receptor antagon

186 pecific receptor antagonist (IL-1Ra) and the decoy receptor IL-1 receptor type 2 (IL-1R2).

187 IL-13 saturated fraction of the circulating decoy receptor IL-13Ralpha2.

188 Our data demonstrate that the decoy receptor IL-1R2 plays an important inhibitory role

189 It functioned as a decoy receptor inhibiting BAFF- and APRIL-mediated B cel

190 erleukin-1 receptor type 2 (IL1R2) acts as a decoy receptor of exogenous IL-1; however, its intracell

191 NF-kappaB, its ligand RANKL, and the soluble decoy receptor osteoprotegerin are the key regulators of

192 Osteoprotegerin (OPG), a decoy receptor secreted by osteoblasts, is a major negat

193 adial glia control this process via the Vegf decoy receptor sFlt1: sflt1 mutants exhibit the venous o

194 In contrast, liposomes containing a decoy receptor show weak antiviral activity due to the l

195 pha chain, or treatment with a soluble IL-33 decoy receptor significantly reduced release of inflamma

196 Both IL-33 effector function, via its decoy receptor sST2, and Col3 synthesis are regulated by

197 chemokine receptor 2 (ACKR2) is a chemokine decoy receptor that binds and scavenges inflammatory CC

198 treatment of CD patients with etanercept, a decoy receptor that binds soluble TNF, fails to improve

199 The first is a decoy receptor that competes for activating ligands.

200 1 (mVEGFR1) is an endothelial cell-intrinsic decoy receptor that negatively modulates blood vessel mo

201 ering a second-generation, high-affinity AXL decoy receptor with an apparent affinity of 93 femtomola

202 orm of IL23R mRNA (which then functions as a decoy receptor) and lowers the ability to develop a Th17

203 via antibody binding or VEGF trap (a soluble decoy receptor) is associated with renal-specific thromb

204 f WT mice with soluble IL-33 receptor (IL-33 decoy receptor) markedly reduced CCI-induced hyperalgesi

205 r that protects against ZIKV by serving as a decoy receptor, and plays a protective role in ZIKV-medi

206 n primary ASMC migration and the role of the decoy receptor, Duffy AgR for chemokines (DARC), in this

207 aintained at pH 6.2, but the activity of the decoy receptor, IL-1R2, is reduced.

208 we show that IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse hum

209 Our decoy receptor, MYD1-72, profoundly inhibited disease pr

210 The CD40 decoy receptor, sCD40R, may serve as a potential therape

211 encoding both the IL-33 receptor, ST2L, and decoy receptor, sST2, has been genetically associated wi

212 Lastly, dysregulated IL-33 signaling via the decoy receptor, sST2, predicts C. difficile-associated m

213 rresponding to the naturally occurring IL-33 decoy receptor.

214 t1 (VEGFR1), a VEGFA receptor that acts as a decoy receptor.

215 -ED into the airway lumen as a hyperadhesive decoy receptor.

216 IL-18BP) acts as a naturally occurring IL-18 decoy receptor.

217 Our data indicate sCD48 as a SEB-induced 'decoy' receptor derived from eosinophil and therefore as

218 Serving as decoys, receptor mimics may lessen symptoms while avoidi

219 The development of a decoy-receptor fusion protein suggests a strategy for th

220 The inhibitory decoy receptors (DcR1 and DcR2) co-expressed with death

221 ode soluble TNFR2 homologs, termed viral TNF decoy receptors (vTNFRs), that display unique specificit

222 eveal a previously underappreciated role for decoy receptors as molecular rheostats in controlling th

223 R signaling and suggest that they can act as decoy receptors for self-antigens that are recognized by

224 ection of cells, or alternatively can act as decoy receptors that bind virions and block virus infect

225 assembly, mimicking the biological effect of decoy receptors that lack the death domain to trigger ap

226 ulated that targeting the type I and type II decoy receptors used by poxvirus to subvert the host inn

227 Their soluble isoforms, functioning as decoy receptors, contain only the ectodomain.

228 LR3 and TRAILR4 are generally referred to as decoy receptors, which have been shown to inhibit TRAIL-

229 ressed homolog of conserved FGFRL/nou-darake decoy receptors.

230 eptors and thus are likely to be viral SLAMF decoy receptors.

231 ACE2 and S and for engineering high-affinity decoy receptors.

232 results show that OPUS-DOSP has an increased decoy recognition capability comparing with those of oth

233 Because the decoy replicates the spike protein target interface in h

234 Using directed evolution, we engineered a 'decoy-resistant' IL-18 (DR-18) that maintains signalling

235 in terms of GDT, when using 2000 and 20,000 decoys, respectively, while reducing significantly the n

236 in archival NSCLC samples, functioning as a decoy RNA for miR-339-3p, -663b-3p, and -95-5p.

237 in vivo and to assess the prospects of using decoy RNAs in antiviral therapy.

238 ry rate estimation method, based on a target-decoy search approach, is derived for assigning confiden

239 t investigations into energy landscape-based decoy selection approaches show promises.

240 varied success in handling the challenge of decoy selection despite some issues associated with clus

241 ameworks in achieving robust performance for decoy selection in template-free protein structure predi

242 We propose a novel decoy selection method, ML-Select, a machine learning fr

243 neural network-based approach named DOcking decoy selection with Voxel-based deep neural nEtwork (DO

244 ML-Select is a useful method for decoy selection.

245 ing and uptake experiments, and fluorescence decoy sensor assays.

246 samples (native and non-native decoys) in a decoy set makes the problem even more complicated.

247 The decoys, set to emit a signal once an hour, provided five

248 some issues associated with clustering large decoy sets and decoy sets that do not show much structur

249 Meanwhile, most protein decoy sets are pre-calculated and there is a lack of met

250 OPUS-DOSP was tested on 11 decoy sets commonly used for statistical potential bench

251 -Select shows promising results even for the decoy sets consisting of mostly low-quality decoys.

252 However, almost all the decoy sets currently used in literature suffer from unev

253 le to generate high-accuracy predictions and decoy sets enriched with near-native loop conformations,

254 ethod was benchmarked with three widely used decoy sets from ab initio folding and comparative modeli

255 lkit, a computational resource including (i) decoy sets generated by different RNA 3D structure predi

256 ociated with clustering large decoy sets and decoy sets that do not show much structural similarity.

257 selecting the native protein structures from decoy sets.

258 rmations in the Rosetta and I-TASSER protein decoy sets.

259 We investigate the role of such "decoy sites" in controlling noise (random fluctuations)

260 TDAs use a database of decoy species to faithfully model score distributions of

261 tion by RapZ of GlmZ and the closely related decoy sRNA, GlmY.

262 ing on the three classic effects, we sampled decoy stimuli exhaustively across bidimensional multiatt

263 Thus, this apoplastic decoy strategy may be widely used in Phytophthora pathos

264 ntification was performed employing a target-decoy strategy.

265 here has been no systematic benchmark set or decoy structures available for the 3D structure predicti

266 h are much better than unrefined structures; decoy structures generated for 89 NMR structures; and co

267 potentials and used to discriminate between decoy structures produced by RosettaAntibody and predict

268 ng domain (MBD), however, DNA methylation of decoys substantially ( approximately 10-30-fold) acceler

269 etitive" environment including an additional decoy substrate, several qualitatively distinct reaction

270 in 1995 to the recent deployment of the PBS1 decoy system in crops.

271 tationary phases (54 distinct systems and 16 decoy systems) in micellar electrokinetic chromatography

272 We use these artificial liposomes as decoy targets to sequester bacterial toxins that are pro

273 s, such as antisense or Transcription Factor Decoys (TFDs), have the potential to circumvent current

274 erexpression of a 5' stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IG

275 ions is an ability to act as scaffolds or as decoys that recruit or sequester effector proteins from

276 em by viruses is often mediated by molecular decoys that sequester host proteins pivotal to mounting

277 These sequences potentially serve as natural decoys that sequester transcription factors.

278 perception and early signalling machinery to decoy the plants defence systems.

279 By acting as macrophage decoys, these nanoparticles bind and neutralize endotoxi

280 anti-inflammatory therapies based on soluble decoy TNFRs.

281 d with increasing distance from the predator decoy to examine how herbivorous fishes reconcile the co

282 , upregulated during regeneration, acts as a decoy to inhibit PDGF signalling and to prevent FAP over

283 oncoding transcript that functions as an RNA decoy to sequester PKR in an inactive state.

284 ture imposes generation of a large number of decoys to explore adequately the solution space, limitin

285 show that they function as decoys to mitigate bacterial toxins.

286 uman angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome c

287 h significantly reduced interaction with the decoy TRAIL receptors 3 and 4.

288 llected clutches of turtle eggs containing a decoy transmitter enabled us to track the movements of t

289 h during peak mosquito abundance, this "host decoy" trap caught nearly ten times the number of Anophe

290 of mHtt exclude chromatin and form 'sticky' decoy traps that impede target search processes of key r

291 Exactly how and why decoys trigger this effect is not known.

292 ed shRNAs via codelivery of inhibitory tough decoy (TuD) RNAs.

293 field-tested the InvestEGGator, a 3D-printed decoy turtle egg embedded with a GPS-GSM transmitter (Su

294 on of Notch, using a soluble receptor Notch1 decoy, unexpectedly caused a remarkable increase in live

295 e, we develop a nanodisc incorporated with a decoy virus receptor that inhibits virus infection.

296 Using data provided by the decoys, we identified trafficking routes and on two occa

297 that fishes foraging closest to the predator decoy were 40% smaller than those that foraged at furthe

298 ory response and of soluble RAGE acting as a decoy were associated with up-regulation of the DAMP-rel

299 ed in a fragment assembly protocol to sample decoys, which are assessed by a composite scoring functi

300 hydrogen-bonding network and compactness of decoys, which eliminates the possibility of native struc